| Literature DB >> 8449019 |
V E Cullins1, P D Blumenthal, R E Remsburg, G R Huggins.
Abstract
Norplant, the five-year subdermal contraceptive system, is the first implantable contraceptive method approved for general use in the United States. We describe the preliminary experiences of 246 U.S. women who accepted Norplant between April, 1991 and September, 1991. Norplant was well accepted among this diverse general population. Intensive counselling about side effects, especially menstrual changes, is crucial for patient satisfaction. Although 48% of acceptors experienced menstrual cycle changes and 70% experienced at least one side effect, phone calls and unscheduled visits for problems were infrequent. Adequate counselling about side effects obviates the need for a routine follow-up visit one month after insertion.Entities:
Keywords: Americas; Behavior; Blacks--women; Clinic Activities; Contraception; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Effectiveness; Contraceptive Implants--cost; Contraceptive Methods--cost; Counseling; Cultural Background; Demographic Factors; Developed Countries; Diseases; Ethnic Groups; Family Planning; Follow-up Studies; Insertion; Levonorgestrel--side effects; Marital Status; Maryland; Menstruation Disorders; North America; Northern America; Nuptiality; Organization And Administration; Perception; Population; Population Characteristics; Program Activities; Program Evaluation; Programs; Psychological Factors; Research Methodology; Research Report; Satisfaction; Studies; Treatment; United States; Unmarried--women; Urban Population--women; Whites--women
Mesh：
Substances：
Year: 1993 PMID： 8449019 DOI： 10.1016/0010-7824(93)90091-k
Source DB: PubMed Journal: Contraception ISSN： 0010-7824 Impact factor: 3.375